The authors showed that sorted CD26+ LSCs were confirmed to be BCR-ABL+ in short- and long-term colony cells derived from CD26+ and CD26− LSCs from CML patients. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.